Table of Content

1 Haemophilus Influenzae Type B Vaccine Market Overview
1.1 Product Overview and Scope of Haemophilus Influenzae Type B Vaccine
1.2 Haemophilus Influenzae Type B Vaccine Segment by Type
1.2.1 Global Haemophilus Influenzae Type B Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Liquid Monovalent HIB
1.2.3 Liquid Combination HIB
1.2.4 Lyophilized Monovalent HIB
1.2.5 Lyophilized Combination HIB
1.3 Haemophilus Influenzae Type B Vaccine Segment by Application
1.3.1 Haemophilus Influenzae Type B Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Haemophilus Influenzae Type B Vaccine Revenue 2016-2027
1.4.2 Global Haemophilus Influenzae Type B Vaccine Sales 2016-2027
1.4.3 Haemophilus Influenzae Type B Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Haemophilus Influenzae Type B Vaccine Market Competition by Manufacturers
2.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Haemophilus Influenzae Type B Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Haemophilus Influenzae Type B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Haemophilus Influenzae Type B Vaccine Market Competitive Situation and Trends
2.5.1 Haemophilus Influenzae Type B Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue
2.5.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario by Region
3.1 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.3.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country
3.3.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.4.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country
3.4.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region
3.5.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country
3.6.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country
3.7.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Haemophilus Influenzae Type B Vaccine Historic Market Analysis by Type
4.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type (2016-2021)

5 Global Haemophilus Influenzae Type B Vaccine Historic Market Analysis by Application
5.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Takeda Pharmaceuticals Company
6.5.1 Takeda Pharmaceuticals Company Corporation Information
6.5.2 Takeda Pharmaceuticals Company Description and Business Overview
6.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Takeda Pharmaceuticals Company Product Portfolio
6.5.5 Takeda Pharmaceuticals Company Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Walvax Biotechnology Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Lanzhou Institute of Biologica
6.6.1 Lanzhou Institute of Biologica Corporation Information
6.6.2 Lanzhou Institute of Biologica Description and Business Overview
6.6.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lanzhou Institute of Biologica Product Portfolio
6.7.5 Lanzhou Institute of Biologica Recent Developments/Updates
6.8 Immunize BC
6.8.1 Immunize BC Corporation Information
6.8.2 Immunize BC Description and Business Overview
6.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Immunize BC Product Portfolio
6.8.5 Immunize BC Recent Developments/Updates

7 Haemophilus Influenzae Type B Vaccine Manufacturing Cost Analysis
7.1 Haemophilus Influenzae Type B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
7.4 Haemophilus Influenzae Type B Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Haemophilus Influenzae Type B Vaccine Distributors List
8.3 Haemophilus Influenzae Type B Vaccine Customers

9 Haemophilus Influenzae Type B Vaccine Market Dynamics
9.1 Haemophilus Influenzae Type B Vaccine Industry Trends
9.2 Haemophilus Influenzae Type B Vaccine Growth Drivers
9.3 Haemophilus Influenzae Type B Vaccine Market Challenges
9.4 Haemophilus Influenzae Type B Vaccine Market Restraints

10 Global Market Forecast
10.1 Haemophilus Influenzae Type B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Haemophilus Influenzae Type B Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Haemophilus Influenzae Type B Vaccine by Type (2022-2027)
10.2 Haemophilus Influenzae Type B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Haemophilus Influenzae Type B Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Haemophilus Influenzae Type B Vaccine by Application (2022-2027)
10.3 Haemophilus Influenzae Type B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Haemophilus Influenzae Type B Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Haemophilus Influenzae Type B Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Haemophilus Influenzae Type B Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Haemophilus Influenzae Type B Vaccine Covered in This Study
Table 5. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Haemophilus Influenzae Type B Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Haemophilus Influenzae Type B Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
Table 12. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021) & (M Doses)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses)
Table 19. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2016-2021)
Table 39. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Haemophilus Influenzae Type B Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2016-2021)
Table 44. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Haemophilus Influenzae Type B Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Novartis Haemophilus Influenzae Type B Vaccine Product
Table 52. Novartis Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Merck Haemophilus Influenzae Type B Vaccine Product
Table 57. Merck Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Sanofi Haemophilus Influenzae Type B Vaccine Product
Table 62. Sanofi Recent Developments/Updates
Table 63. GlaxoSmithKline Corporation Information
Table 64. GlaxoSmithKline Description and Business Overview
Table 65. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product
Table 67. GlaxoSmithKline Recent Developments/Updates
Table 68. Takeda Pharmaceuticals Company Corporation Information
Table 69. Takeda Pharmaceuticals Company Description and Business Overview
Table 70. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product
Table 72. Takeda Pharmaceuticals Company Recent Developments/Updates
Table 73. Walvax Biotechnology Corporation Information
Table 74. Walvax Biotechnology Description and Business Overview
Table 75. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product
Table 77. Walvax Biotechnology Recent Developments/Updates
Table 78. Lanzhou Institute of Biologica Corporation Information
Table 79. Lanzhou Institute of Biologica Description and Business Overview
Table 80. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product
Table 82. Lanzhou Institute of Biologica Recent Developments/Updates
Table 83. Immunize BC Corporation Information
Table 84. Immunize BC Description and Business Overview
Table 85. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Immunize BC Haemophilus Influenzae Type B Vaccine Product
Table 87. Immunize BC Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Haemophilus Influenzae Type B Vaccine Distributors List
Table 91. Haemophilus Influenzae Type B Vaccine Customers List
Table 92. Haemophilus Influenzae Type B Vaccine Market Trends
Table 93. Haemophilus Influenzae Type B Vaccine Growth Drivers
Table 94. Haemophilus Influenzae Type B Vaccine Market Restraints
Table 95. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 96. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 100. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Haemophilus Influenzae Type B Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 104. Global Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Haemophilus Influenzae Type B Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Haemophilus Influenzae Type B Vaccine
Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2020 & 2027
Figure 3. Liquid Monovalent HIB Product Picture
Figure 4. Liquid Combination HIB Product Picture
Figure 5. Lyophilized Monovalent HIB Product Picture
Figure 6. Lyophilized Combination HIB Product Picture
Figure 7. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Research Institutions
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Academic Institutions
Figure 12. Other
Figure 13. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Haemophilus Influenzae Type B Vaccine Market Size 2016-2027 (US$ Million)
Figure 15. Global Haemophilus Influenzae Type B Vaccine Sales 2016-2027 (M Doses)
Figure 16. Global Haemophilus Influenzae Type B Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers in 2020
Figure 18. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Haemophilus Influenzae Type B Vaccine Players: Market Share by Revenue in 2020
Figure 20. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2021)
Figure 22. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region in 2020
Figure 23. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2016-2021)
Figure 24. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in 2020
Figure 25. U.S. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Haemophilus Influenzae Type B Vaccine by Type (2016-2021)
Figure 50. Sales Market Share of Haemophilus Influenzae Type B Vaccine by Application (2016-2021)
Figure 51. Sales Market Share of Haemophilus Influenzae Type B Vaccine by Application in 2020
Figure 52. Revenue Share of Haemophilus Influenzae Type B Vaccine by Application (2016-2021)
Figure 53. Revenue Share of Haemophilus Influenzae Type B Vaccine by Application in 2020
Figure 54. Manufacturing Cost Structure of Haemophilus Influenzae Type B Vaccine
Figure 55. Manufacturing Process Analysis of Haemophilus Influenzae Type B Vaccine
Figure 56. Haemophilus Influenzae Type B Vaccine Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed